ID   UB2D3_HUMAN             Reviewed;         147 AA.
AC   P61077; A6NJ93; A6NJB1; A6NM99; P47986; Q6IB88; Q6NXS4; Q8N924;
DT   26-APR-2004, integrated into UniProtKB/Swiss-Prot.
DT   26-APR-2004, sequence version 1.
DT   10-MAY-2017, entry version 145.
DE   RecName: Full=Ubiquitin-conjugating enzyme E2 D3;
DE            EC=2.3.2.23 {ECO:0000269|PubMed:20061386};
DE   AltName: Full=(E3-independent) E2 ubiquitin-conjugating enzyme D3;
DE            EC=2.3.2.24 {ECO:0000269|PubMed:17588522};
DE   AltName: Full=E2 ubiquitin-conjugating enzyme D3;
DE   AltName: Full=Ubiquitin carrier protein D3;
DE   AltName: Full=Ubiquitin-conjugating enzyme E2(17)KB 3;
DE   AltName: Full=Ubiquitin-conjugating enzyme E2-17 kDa 3;
DE   AltName: Full=Ubiquitin-protein ligase D3;
GN   Name=UBE2D3; Synonyms=UBC5C, UBCH5C;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=8530467; DOI=10.1074/jbc.270.51.30408;
RA   Jensen J.P., Bates P.W., Yang M., Vierstra R.D., Weissman A.M.;
RT   "Identification of a family of closely related human ubiquitin
RT   conjugating enzymes.";
RL   J. Biol. Chem. 270:30408-30414(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Chang H.-M., Tsai S.-F.;
RT   "Genome sequencing of the chromosome 4q region implicated in human
RT   hepatocellular carcinoma pathogenesis.";
RL   Submitted (DEC-1999) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3).
RC   TISSUE=Chondrocyte, and Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain, and Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   FUNCTION, AND MUTAGENESIS OF CYS-85.
RX   PubMed=10329681; DOI=10.1074/jbc.274.21.14823;
RA   Gonen H., Bercovich B., Orian A., Carrano A., Takizawa C.,
RA   Yamanaka K., Pagano M., Iwai K., Ciechanover A.;
RT   "Identification of the ubiquitin carrier proteins, E2s, involved in
RT   signal-induced conjugation and subsequent degradation of
RT   IkappaBalpha.";
RL   J. Biol. Chem. 274:14823-14830(1999).
RN   [9]
RP   FUNCTION.
RX   PubMed=11743028; DOI=10.1093/embo-reports/kve246;
RA   Murata S., Minami Y., Minami M., Chiba T., Tanaka K.;
RT   "CHIP is a chaperone-dependent E3 ligase that ubiquitylates unfolded
RT   protein.";
RL   EMBO Rep. 2:1133-1138(2001).
RN   [10]
RP   FUNCTION.
RX   PubMed=12646252; DOI=10.1016/S0006-291X(03)00282-1;
RA   Yogosawa S., Miyauchi Y., Honda R., Tanaka H., Yasuda H.;
RT   "Mammalian Numb is a target protein of Mdm2, ubiquitin ligase.";
RL   Biochem. Biophys. Res. Commun. 302:869-872(2003).
RN   [11]
RP   FUNCTION.
RX   PubMed=15247280; DOI=10.1074/jbc.C400300200;
RA   Rajendra R., Malegaonkar D., Pungaliya P., Marshall H., Rasheed Z.,
RA   Brownell J., Liu L.F., Lutzker S., Saleem A., Rubin E.H.;
RT   "Topors functions as an E3 ubiquitin ligase with specific E2 enzymes
RT   and ubiquitinates p53.";
RL   J. Biol. Chem. 279:36440-36444(2004).
RN   [12]
RP   FUNCTION.
RX   PubMed=15280377; DOI=10.1074/jbc.M403362200;
RA   Saville M.K., Sparks A., Xirodimas D.P., Wardrop J., Stevenson L.F.,
RA   Bourdon J.C., Woods Y.L., Lane D.P.;
RT   "Regulation of p53 by the ubiquitin-conjugating enzymes UbcH5B/C in
RT   vivo.";
RL   J. Biol. Chem. 279:42169-42181(2004).
RN   [13]
RP   FUNCTION.
RX   PubMed=15496420; DOI=10.1074/jbc.M410583200;
RA   Huang J., Huang Q., Zhou X., Shen M.M., Yen A., Yu S.X., Dong G.,
RA   Qu K., Huang P., Anderson E.M., Daniel-Issakani S., Buller R.M.,
RA   Payan D.G., Lu H.H.;
RT   "The poxvirus p28 virulence factor is an E3 ubiquitin ligase.";
RL   J. Biol. Chem. 279:54110-54116(2004).
RN   [14]
RP   INTERACTION WITH BRCA1, AND FUNCTION.
RX   PubMed=16628214; DOI=10.1038/sj.emboj.7601102;
RA   Polanowska J., Martin J.S., Garcia-Muse T., Petalcorin M.I.R.,
RA   Boulton S.J.;
RT   "A conserved pathway to activate BRCA1-dependent ubiquitylation at DNA
RT   damage sites.";
RL   EMBO J. 25:2178-2188(2006).
RN   [15]
RP   CATALYTIC ACTIVITY AS E3-INDEPENDENT E2 UBIQUITIN-CONJUGATING ENZYME.
RX   PubMed=17588522; DOI=10.1016/j.molcel.2007.05.014;
RA   Hoeller D., Hecker C.M., Wagner S., Rogov V., Doetsch V., Dikic I.;
RT   "E3-independent monoubiquitination of ubiquitin-binding proteins.";
RL   Mol. Cell 26:891-898(2007).
RN   [16]
RP   INTERACTION WITH DAPK3, AND FUNCTION.
RX   PubMed=18515077; DOI=10.1016/j.bbrc.2008.05.113;
RA   Ohbayashi N., Okada K., Kawakami S., Togi S., Sato N., Ikeda O.,
RA   Kamitani S., Muromoto R., Sekine Y., Kawai T., Akira S., Matsuda T.;
RT   "Physical and functional interactions between ZIP kinase and UbcH5.";
RL   Biochem. Biophys. Res. Commun. 372:708-712(2008).
RN   [17]
RP   FUNCTION.
RX   PubMed=18948756; DOI=10.4161/cc.7.21.6949;
RA   Zhang S., Chea J., Meng X., Zhou Y., Lee E.Y.C., Lee M.Y.W.T.;
RT   "PCNA is ubiquitinated by RNF8.";
RL   Cell Cycle 7:3399-3404(2008).
RN   [18]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=18508924; DOI=10.1091/mbc.E07-10-0988;
RA   Umebayashi K., Stenmark H., Yoshimori T.;
RT   "Ubc4/5 and c-Cbl continue to ubiquitinate EGF receptor after
RT   internalization to facilitate polyubiquitination and degradation.";
RL   Mol. Biol. Cell 19:3454-3462(2008).
RN   [19]
RP   INTERACTION WITH SCF COMPLEX.
RX   PubMed=18851830; DOI=10.1016/j.molcel.2008.08.021;
RA   Saha A., Deshaies R.J.;
RT   "Multimodal activation of the ubiquitin ligase SCF by Nedd8
RT   conjugation.";
RL   Mol. Cell 32:21-31(2008).
RN   [20]
RP   FUNCTION.
RX   PubMed=18284575; DOI=10.1111/j.1365-2958.2008.06124.x;
RA   Kubori T., Hyakutake A., Nagai H.;
RT   "Legionella translocates an E3 ubiquitin ligase that has multiple U-
RT   boxes with distinct functions.";
RL   Mol. Microbiol. 67:1307-1319(2008).
RN   [21]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=20061386; DOI=10.1074/jbc.M109.089003;
RA   David Y., Ziv T., Admon A., Navon A.;
RT   "The E2 ubiquitin-conjugating enzymes direct polyubiquitination to
RT   preferred lysines.";
RL   J. Biol. Chem. 285:8595-8604(2010).
RN   [22]
RP   INTERACTION WITH CBLC.
RX   PubMed=20525694; DOI=10.1074/jbc.M109.091157;
RA   Ryan P.E., Sivadasan-Nair N., Nau M.M., Nicholas S., Lipkowitz S.;
RT   "The N terminus of Cbl-c regulates ubiquitin ligase activity by
RT   modulating affinity for the ubiquitin-conjugating enzyme.";
RL   J. Biol. Chem. 285:23687-23698(2010).
RN   [23]
RP   FUNCTION.
RX   PubMed=20347421; DOI=10.1016/j.molcel.2010.02.025;
RA   Wu K., Kovacev J., Pan Z.Q.;
RT   "Priming and extending: a UbcH5/Cdc34 E2 handoff mechanism for
RT   polyubiquitination on a SCF substrate.";
RL   Mol. Cell 37:784-796(2010).
RN   [24]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [25]
RP   FUNCTION, AND MUTAGENESIS OF ASN-77; ASP-87 AND ASP-117.
RX   PubMed=21532592; DOI=10.1038/nature09966;
RA   Wenzel D.M., Lissounov A., Brzovic P.S., Klevit R.E.;
RT   "UBCH7 reactivity profile reveals parkin and HHARI to be RING/HECT
RT   hybrids.";
RL   Nature 474:105-108(2011).
RN   [26]
RP   INTERACTION WITH UBTD1.
RX   PubMed=24211586; DOI=10.1016/j.bbrc.2013.10.137;
RA   Uhler J.P., Spaahr H., Farge G., Clavel S., Larsson N.G.,
RA   Falkenberg M., Samuelsson T., Gustafsson C.M.;
RT   "The UbL protein UBTD1 stably interacts with the UBE2D family of E2
RT   ubiquitin conjugating enzymes.";
RL   Biochem. Biophys. Res. Commun. 443:7-12(2014).
RN   [27]
RP   STRUCTURE BY NMR OF 2-147 IN COMPLEX WITH THE BRCA1/BARD1 RING-DOMAIN
RP   HETERODIMER, AND INTERACTION WITH BRCA1.
RX   PubMed=16543155; DOI=10.1016/j.molcel.2006.02.008;
RA   Brzovic P.S., Lissounov A., Christensen D.E., Hoyt D.W., Klevit R.E.;
RT   "A UbcH5/ubiquitin noncovalent complex is required for processive
RT   BRCA1-directed ubiquitination.";
RL   Mol. Cell 21:873-880(2006).
RN   [28]
RP   X-RAY CRYSTALLOGRAPHY (1.85 ANGSTROMS) OF 1-147, AND DISULFIDE BOND.
RA   Nakanishi M., Teshima N., Mizushima T., Murata S., Tanaka K.,
RA   Yamane T.;
RT   "Crystal structure of UBCH5C.";
RL   Submitted (FEB-2009) to the PDB data bank.
RN   [29]
RP   X-RAY CRYSTALLOGRAPHY (3.17 ANGSTROMS) OF 1-147 IN COMPLEX WITH U-BOX
RP   DOMAIN OF UBE4B.
RA   Benirschke R., Thompson J.R., Mer G.;
RT   "Crystal structure of the U-Box domain of human e4b ubiquitin ligase
RT   in complex with UBCH5C E2 ubiquitin conjugating enzyme.";
RL   Submitted (MAY-2010) to the PDB data bank.
CC   -!- FUNCTION: Accepts ubiquitin from the E1 complex and catalyzes its
CC       covalent attachment to other proteins. In vitro catalyzes 'Lys-
CC       11'-, as well as 'Lys-48'-linked polyubiquitination. Cooperates
CC       with the E2 CDC34 and the SCF(FBXW11) E3 ligase complex for the
CC       polyubiquitination of NFKBIA leading to its subsequent proteasomal
CC       degradation. Acts as an initiator E2, priming the phosphorylated
CC       NFKBIA target at positions 'Lys-21' and/or 'Lys-22' with a
CC       monoubiquitin. Ubiquitin chain elongation is then performed by
CC       CDC34, building ubiquitin chains from the UBE2D3-primed NFKBIA-
CC       linked ubiquitin. Acts also as an initiator E2, in conjunction
CC       with RNF8, for the priming of PCNA. Monoubiquitination of PCNA,
CC       and its subsequent polyubiquitination, are essential events in the
CC       operation of the DNA damage tolerance (DDT) pathway that is
CC       activated after DNA damage caused by UV or chemical agents during
CC       S-phase. Associates with the BRCA1/BARD1 E3 ligase complex to
CC       perform ubiquitination at DNA damage sites following ionizing
CC       radiation leading to DNA repair. Targets DAPK3 for ubiquitination
CC       which influences promyelocytic leukemia protein nuclear body (PML-
CC       NB) formation in the nucleus. In conjunction with the MDM2 and
CC       TOPORS E3 ligases, functions ubiquitination of p53/TP53. Supports
CC       NRDP1-mediated ubiquitination and degradation of ERBB3 and of
CC       BRUCE which triggers apoptosis. In conjunction with the CBL E3
CC       ligase, targets EGFR for polyubiquitination at the plasma membrane
CC       as well as during its internalization and transport on endosomes.
CC       In conjunction with the STUB1 E3 quality control E3 ligase,
CC       ubiquitinates unfolded proteins to catalyze their immediate
CC       destruction. {ECO:0000269|PubMed:10329681,
CC       ECO:0000269|PubMed:11743028, ECO:0000269|PubMed:12646252,
CC       ECO:0000269|PubMed:15247280, ECO:0000269|PubMed:15280377,
CC       ECO:0000269|PubMed:15496420, ECO:0000269|PubMed:16628214,
CC       ECO:0000269|PubMed:18284575, ECO:0000269|PubMed:18508924,
CC       ECO:0000269|PubMed:18515077, ECO:0000269|PubMed:18948756,
CC       ECO:0000269|PubMed:20061386, ECO:0000269|PubMed:20347421,
CC       ECO:0000269|PubMed:21532592}.
CC   -!- CATALYTIC ACTIVITY: S-ubiquitinyl-[E1 ubiquitin-activating
CC       enzyme]-L-cysteine + [E2 ubiquitin-conjugating enzyme]-L-cysteine
CC       = [E1 ubiquitin-activating enzyme]-L-cysteine + S-ubiquitinyl-[E2
CC       ubiquitin-conjugating enzyme]-L-cysteine. {ECO:0000255|PROSITE-
CC       ProRule:PRU00388, ECO:0000255|PROSITE-ProRule:PRU10133,
CC       ECO:0000269|PubMed:20061386}.
CC   -!- CATALYTIC ACTIVITY: S-ubiquitinyl-[E1 ubiquitin-activating
CC       enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E1 ubiquitin-
CC       activating enzyme]-L-cysteine + N(6)-monoubiquitinyl-[acceptor
CC       protein]-L-lysine. {ECO:0000269|PubMed:17588522}.
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC       {ECO:0000255|PROSITE-ProRule:PRU00388}.
CC   -!- SUBUNIT: Interacts with SCF (SKP1-CUL1-F-box protein) E3 ubiquitin
CC       ligase complex; when Cullin is neddylated, the interaction between
CC       the E2 and the SCF complex is strengthened. Interacts with DAPK3.
CC       Interacts with BRCA1; the DNA damage checkpoint promotes the
CC       association with BRCA1 after ionizing radiation. Interacts non-
CC       covalently with ubiquitin. Interacts with E3 ubiquitin-protein
CC       ligase CBLC. Interacts with UBTD1 (PubMed:24211586).
CC       {ECO:0000269|PubMed:16543155, ECO:0000269|PubMed:16628214,
CC       ECO:0000269|PubMed:18515077, ECO:0000269|PubMed:18851830,
CC       ECO:0000269|PubMed:20525694, ECO:0000269|PubMed:24211586,
CC       ECO:0000269|Ref.29}.
CC   -!- INTERACTION:
CC       O54784:Dapk3 (xeno); NbExp=2; IntAct=EBI-348268, EBI-77359;
CC       Q4ZH49:DTX2; NbExp=3; IntAct=EBI-348268, EBI-10192429;
CC       Q86UW9:DTX2; NbExp=5; IntAct=EBI-348268, EBI-740376;
CC       O15344:MID1; NbExp=6; IntAct=EBI-348268, EBI-2340316;
CC       Q99PZ6:ospG (xeno); NbExp=6; IntAct=EBI-348268, EBI-9316527;
CC       Q96FW1:OTUB1; NbExp=13; IntAct=EBI-348268, EBI-1058491;
CC       Q9Y3C5:RNF11; NbExp=3; IntAct=EBI-348268, EBI-396669;
CC       Q6ZNA4:RNF111; NbExp=5; IntAct=EBI-348268, EBI-2129175;
CC       Q9Y4L5:RNF115; NbExp=6; IntAct=EBI-348268, EBI-2129242;
CC       Q9BV68:RNF126; NbExp=5; IntAct=EBI-348268, EBI-357322;
CC       Q99496:RNF2; NbExp=3; IntAct=EBI-348268, EBI-722416;
CC       Q68DV7:RNF43; NbExp=2; IntAct=EBI-348268, EBI-1647060;
CC       Q99942:RNF5; NbExp=8; IntAct=EBI-348268, EBI-348482;
CC       P0CE12:sspH2 (xeno); NbExp=7; IntAct=EBI-348268, EBI-10761075;
CC       Q9Y4K3:TRAF6; NbExp=2; IntAct=EBI-348268, EBI-359276;
CC       Q9HCM9:TRIM39; NbExp=5; IntAct=EBI-348268, EBI-739510;
CC       P98170:XIAP; NbExp=2; IntAct=EBI-348268, EBI-517127;
CC       Q8ND25:ZNRF1; NbExp=3; IntAct=EBI-348268, EBI-2129250;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:18508924};
CC       Peripheral membrane protein {ECO:0000269|PubMed:18508924}.
CC       Endosome membrane {ECO:0000269|PubMed:18508924}; Peripheral
CC       membrane protein {ECO:0000269|PubMed:18508924}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P61077-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P61077-2; Sequence=VSP_038097;
CC       Name=3;
CC         IsoId=P61077-3; Sequence=VSP_038096;
CC   -!- PTM: Phosphorylated by AURKB. {ECO:0000250|UniProtKB:P61079}.
CC   -!- SIMILARITY: Belongs to the ubiquitin-conjugating enzyme family.
CC       {ECO:0000255|PROSITE-ProRule:PRU00388}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U39318; AAA91461.1; -; mRNA.
DR   EMBL; AF213884; AAF35234.1; -; Genomic_DNA.
DR   EMBL; AK095822; BAC04632.1; -; mRNA.
DR   EMBL; DB045280; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; CR456916; CAG33197.1; -; mRNA.
DR   EMBL; AC018797; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471057; EAX06138.1; -; Genomic_DNA.
DR   EMBL; CH471057; EAX06143.1; -; Genomic_DNA.
DR   EMBL; BC003395; AAH03395.1; -; mRNA.
DR   EMBL; BC037894; AAH37894.1; -; mRNA.
DR   EMBL; BC066917; AAH66917.1; -; mRNA.
DR   CCDS; CCDS3659.1; -. [P61077-3]
DR   CCDS; CCDS3660.1; -. [P61077-1]
DR   CCDS; CCDS3661.1; -. [P61077-2]
DR   RefSeq; NP_003331.1; NM_003340.6. [P61077-1]
DR   RefSeq; NP_871615.1; NM_181886.3. [P61077-1]
DR   RefSeq; NP_871616.1; NM_181887.2. [P61077-1]
DR   RefSeq; NP_871617.1; NM_181888.3. [P61077-1]
DR   RefSeq; NP_871618.1; NM_181889.2. [P61077-1]
DR   RefSeq; NP_871619.1; NM_181890.2. [P61077-1]
DR   RefSeq; NP_871620.1; NM_181891.2. [P61077-1]
DR   RefSeq; NP_871621.1; NM_181892.3. [P61077-2]
DR   RefSeq; NP_871622.1; NM_181893.2. [P61077-3]
DR   UniGene; Hs.518773; -.
DR   UniGene; Hs.595430; -.
DR   UniGene; Hs.621366; -.
DR   PDB; 1X23; X-ray; 1.85 A; A/B/C/D=1-147.
DR   PDB; 2FUH; NMR; -; A=2-147.
DR   PDB; 3L1Z; X-ray; 3.17 A; A=1-147.
DR   PDB; 3RPG; X-ray; 2.65 A; A=2-147.
DR   PDB; 3UGB; X-ray; 2.35 A; A=1-147.
DR   PDB; 4BVU; X-ray; 2.70 A; B=1-147.
DR   PDB; 4R8P; X-ray; 3.28 A; L/N=2-147.
DR   PDB; 4S3O; X-ray; 2.00 A; A/D=2-147.
DR   PDB; 5EGG; X-ray; 1.76 A; A=1-147.
DR   PDB; 5IFR; X-ray; 2.20 A; A=2-147.
DR   PDBsum; 1X23; -.
DR   PDBsum; 2FUH; -.
DR   PDBsum; 3L1Z; -.
DR   PDBsum; 3RPG; -.
DR   PDBsum; 3UGB; -.
DR   PDBsum; 4BVU; -.
DR   PDBsum; 4R8P; -.
DR   PDBsum; 4S3O; -.
DR   PDBsum; 5EGG; -.
DR   PDBsum; 5IFR; -.
DR   ProteinModelPortal; P61077; -.
DR   SMR; P61077; -.
DR   BioGrid; 113171; 218.
DR   DIP; DIP-29062N; -.
DR   IntAct; P61077; 107.
DR   MINT; MINT-1032046; -.
DR   STRING; 9606.ENSP00000381717; -.
DR   iPTMnet; P61077; -.
DR   PhosphoSitePlus; P61077; -.
DR   DMDM; 46577654; -.
DR   EPD; P61077; -.
DR   MaxQB; P61077; -.
DR   PaxDb; P61077; -.
DR   PeptideAtlas; P61077; -.
DR   PRIDE; P61077; -.
DR   TopDownProteomics; P61077-1; -. [P61077-1]
DR   TopDownProteomics; P61077-2; -. [P61077-2]
DR   Ensembl; ENST00000321805; ENSP00000318494; ENSG00000109332. [P61077-1]
DR   Ensembl; ENST00000338145; ENSP00000337208; ENSG00000109332. [P61077-1]
DR   Ensembl; ENST00000343106; ENSP00000345285; ENSG00000109332. [P61077-2]
DR   Ensembl; ENST00000349311; ENSP00000344069; ENSG00000109332. [P61077-1]
DR   Ensembl; ENST00000357194; ENSP00000349722; ENSG00000109332. [P61077-3]
DR   Ensembl; ENST00000394801; ENSP00000378280; ENSG00000109332. [P61077-1]
DR   Ensembl; ENST00000394803; ENSP00000378282; ENSG00000109332. [P61077-1]
DR   Ensembl; ENST00000394804; ENSP00000378283; ENSG00000109332. [P61077-1]
DR   Ensembl; ENST00000453744; ENSP00000396901; ENSG00000109332. [P61077-1]
DR   GeneID; 7323; -.
DR   KEGG; hsa:7323; -.
DR   UCSC; uc003hwi.5; human. [P61077-1]
DR   CTD; 7323; -.
DR   DisGeNET; 7323; -.
DR   GeneCards; UBE2D3; -.
DR   HGNC; HGNC:12476; UBE2D3.
DR   HPA; HPA003920; -.
DR   MIM; 602963; gene.
DR   neXtProt; NX_P61077; -.
DR   OpenTargets; ENSG00000109332; -.
DR   PharmGKB; PA37126; -.
DR   eggNOG; KOG0417; Eukaryota.
DR   eggNOG; COG5078; LUCA.
DR   GeneTree; ENSGT00760000119012; -.
DR   HOVERGEN; HBG063308; -.
DR   InParanoid; P61077; -.
DR   KO; K06689; -.
DR   OMA; LYKTDRT; -.
DR   OrthoDB; EOG091G0GF8; -.
DR   PhylomeDB; P61077; -.
DR   TreeFam; TF101108; -.
DR   BRENDA; 2.3.2.B6; 2681.
DR   Reactome; R-HSA-1234176; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha.
DR   Reactome; R-HSA-201451; Signaling by BMP.
DR   Reactome; R-HSA-2173795; Downregulation of SMAD2/3:SMAD4 transcriptional activity.
DR   Reactome; R-HSA-8866654; E3 ubiquitin ligases ubiquitinate target proteins.
DR   Reactome; R-HSA-936440; Negative regulators of RIG-I/MDA5 signaling.
DR   Reactome; R-HSA-937041; IKK complex recruitment mediated by RIP1.
DR   Reactome; R-HSA-983168; Antigen processing: Ubiquitination & Proteasome degradation.
DR   SignaLink; P61077; -.
DR   UniPathway; UPA00143; -.
DR   ChiTaRS; UBE2D3; human.
DR   EvolutionaryTrace; P61077; -.
DR   GeneWiki; UBE2D3; -.
DR   GenomeRNAi; 7323; -.
DR   PRO; PR:P61077; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   Bgee; ENSG00000109332; -.
DR   CleanEx; HS_UBE2D3; -.
DR   ExpressionAtlas; P61077; baseline and differential.
DR   Genevisible; P61077; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0010008; C:endosome membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0061631; F:ubiquitin conjugating enzyme activity; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0004842; F:ubiquitin-protein transferase activity; IDA:UniProtKB.
DR   GO; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW.
DR   GO; GO:0030509; P:BMP signaling pathway; TAS:Reactome.
DR   GO; GO:0006464; P:cellular protein modification process; TAS:ProtInc.
DR   GO; GO:0006281; P:DNA repair; IEA:UniProtKB-KW.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; TAS:Reactome.
DR   GO; GO:1903955; P:positive regulation of protein targeting to mitochondrion; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IDA:UniProtKB.
DR   GO; GO:0051865; P:protein autoubiquitination; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0070979; P:protein K11-linked ubiquitination; IDA:UniProtKB.
DR   GO; GO:0070936; P:protein K48-linked ubiquitination; IDA:UniProtKB.
DR   GO; GO:0006513; P:protein monoubiquitination; IDA:UniProtKB.
DR   GO; GO:0000209; P:protein polyubiquitination; IDA:UniProtKB.
DR   GO; GO:0016567; P:protein ubiquitination; IDA:UniProtKB.
DR   GO; GO:0061418; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; TAS:Reactome.
DR   GO; GO:0035666; P:TRIF-dependent toll-like receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; TAS:ProtInc.
DR   CDD; cd00195; UBCc; 1.
DR   Gene3D; 3.10.110.10; -; 1.
DR   InterPro; IPR000608; UBQ-conjugat_E2.
DR   InterPro; IPR023313; UBQ-conjugating_AS.
DR   InterPro; IPR016135; UBQ-conjugating_enzyme/RWD.
DR   Pfam; PF00179; UQ_con; 1.
DR   SUPFAM; SSF54495; SSF54495; 1.
DR   PROSITE; PS00183; UBIQUITIN_CONJUGAT_1; 1.
DR   PROSITE; PS50127; UBIQUITIN_CONJUGAT_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Apoptosis; ATP-binding;
KW   Cell membrane; Complete proteome; Disulfide bond; DNA damage;
KW   DNA repair; Endosome; Membrane; Nucleotide-binding; Phosphoprotein;
KW   Reference proteome; Transferase; Ubl conjugation pathway.
FT   CHAIN         1    147       Ubiquitin-conjugating enzyme E2 D3.
FT                                /FTId=PRO_0000082466.
FT   ACT_SITE     85     85       Glycyl thioester intermediate.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00388,
FT                                ECO:0000255|PROSITE-ProRule:PRU10133}.
FT   DISULFID     21    107       {ECO:0000269|Ref.28}.
FT   VAR_SEQ       1      8       MALKRINK -> MLSNRKCLSK (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_038096.
FT   VAR_SEQ     134    147       YNRISREWTQKYAM -> YNRLAREWTEKYAML (in
FT                                isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_038097.
FT   MUTAGEN      77     77       N->S: Activity is restricted HECT-type
FT                                and not RING-containing E3 ubiquitin-
FT                                protein ligases. Exhibits ubiquitin
FT                                transfer with ARIH1 and PRKN.
FT                                {ECO:0000269|PubMed:21532592}.
FT   MUTAGEN      85     85       C->A: Loss of function.
FT                                {ECO:0000269|PubMed:10329681}.
FT   MUTAGEN      87     87       D->E,P: Has intermediate lysine
FT                                reactivity.
FT                                {ECO:0000269|PubMed:21532592}.
FT   MUTAGEN      87     87       D->K: Abolishes affect lysine reactivity.
FT                                {ECO:0000269|PubMed:21532592}.
FT   MUTAGEN      87     87       D->N: Does not affect lysine reactivity.
FT                                {ECO:0000269|PubMed:21532592}.
FT   MUTAGEN     117    117       D->H: Strongly impairs lysine reactivity
FT                                but retains some ability to transfer
FT                                ubiquitin to BRCA1.
FT                                {ECO:0000269|PubMed:21532592}.
FT   CONFLICT     50     50       Missing (in Ref. 3; DB045280).
FT                                {ECO:0000305}.
FT   CONFLICT    123    123       I -> L (in Ref. 7; AAH66917).
FT                                {ECO:0000305}.
FT   CONFLICT    137    137       I -> V (in Ref. 3; CAG33197).
FT                                {ECO:0000305}.
FT   CONFLICT    147    147       M -> I (in Ref. 3; CAG33197).
FT                                {ECO:0000305}.
FT   HELIX         1     15       {ECO:0000244|PDB:5EGG}.
FT   STRAND       19     21       {ECO:0000244|PDB:2FUH}.
FT   STRAND       22     28       {ECO:0000244|PDB:5EGG}.
FT   STRAND       32     38       {ECO:0000244|PDB:5EGG}.
FT   STRAND       41     43       {ECO:0000244|PDB:4S3O}.
FT   TURN         44     47       {ECO:0000244|PDB:5EGG}.
FT   STRAND       49     55       {ECO:0000244|PDB:5EGG}.
FT   TURN         58     61       {ECO:0000244|PDB:5EGG}.
FT   STRAND       66     71       {ECO:0000244|PDB:5EGG}.
FT   STRAND       76     78       {ECO:0000244|PDB:4R8P}.
FT   STRAND       80     84       {ECO:0000244|PDB:4R8P}.
FT   HELIX        87     89       {ECO:0000244|PDB:5EGG}.
FT   TURN         90     92       {ECO:0000244|PDB:5EGG}.
FT   HELIX        99    111       {ECO:0000244|PDB:5EGG}.
FT   HELIX       121    129       {ECO:0000244|PDB:5EGG}.
FT   HELIX       131    145       {ECO:0000244|PDB:5EGG}.
SQ   SEQUENCE   147 AA;  16687 MW;  ADD74A8A708EFEE3 CRC64;
     MALKRINKEL SDLARDPPAQ CSAGPVGDDM FHWQATIMGP NDSPYQGGVF FLTIHFPTDY
     PFKPPKVAFT TRIYHPNINS NGSICLDILR SQWSPALTIS KVLLSICSLL CDPNPDDPLV
     PEIARIYKTD RDKYNRISRE WTQKYAM
//
